Home / BARDA DRIVe Ez-Baa (EZBAA - 22-100-SOL-00003) / Document

Amendment 27: DRIVe EZ Broad Agency Announcement

Updated

A PDF document (171 KB) attached to BARDA DRIVe Ez-Baa (EZBAA - 22-100-SOL-00003), from the Office of Assistant Secretary for Preparedness and Response. Due Oct 18, 2027, 4:30 PM (UTC-4).

File name: Amendment 027 - DRIVe EZ BAA.pdf

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

EZBAA-22-100-SOL-00003

Amendment #027

Office of Biomedical Advanced Research and Development Authority Division of Research, Innovation & Ventures (DRIVe)
Easy Broad Agency Announcement EZBAA-22-100-SOL-00003

The purpose of Amendment #027 is the following:

1) Reopen the following Area of Interest (AOI):
AOI #20: DRIVe Forward
2) Removing two topic areas and adding one topic area to the following Area of Interest (AOI):
AOI #20: DRIVe Forward

EZBAA-22-100-SOL-00003

Amendment #027

INTRODUCTION AND OVERVIEW INFORMATION

A. Development Opportunity Objective:

Under this Amendment, DRIVe is doing the following:
1)

Reopening the following research Area of Interest (AOI): AOI #20: DRIVe Forward

2)

Removing two topic areas and adding one topic area to the following research Area of Interest (AOI):
AOI #20: DRIVe Forward
Specifically, “Extremely mobile viral diagnostic platforms for use in extremely remote settings” and “Develop computational models to inform precision MCM and nonpharmaceutical intervention (NPI) rapid development and deployment during an outbreak” are removed as topic areas. “Next-generation tourniquets for civilian use” is added as a topic area.

We are now seeking abstract submissions for the following topic areas under the AOI: AOI #20 DRIVe Forward
The continual threat of known and unknown emerging infectious diseases, pandemics, and other public health emergencies requires us to continually invest in products, capabilities, and technologies that have the potential to radically reshape and strengthen our ability to prevent, prepare for, and respond to those emergencies. Specifically, the Division of Research, Innovation, and Ventures (DRIVe) aims to develop products, capabilities, and technologies to rapidly and agnostically detect threats, improve patient care, including ancillary supplies and resources, as well as novel approaches to develop, clinically validate, and deploy/distribute medical countermeasures (MCMs). DRIVe and BARDA already have a variety of specific programs, each focused on specific problems or threat areas of interest, that address this broader aim. DRIVe recognizes, however, that many promising approaches don’t fit into any current program areas but would nonetheless advance DRIVe’s mission. Accordingly, submissions under this DRIVe Forward Area of Interest are designed to capture those blindspots either as a standalone proof of concepts or as a prelude to a potential future program. DRIVe Forward aims to support proposals that

The beginning of the document. Download the full file to read on.

Other documents in this bid